Delivery Order SPE2DB20D1047-SPE2DB25FF48B
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,384.83, is for the supply of the pharmaceutical product ZORYVE 0.3% FOAM 60GM. The contract has a firm fixed price pricing type and a period of performance through February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a firm fixed price ceiling value of $1,392.55. The period of performance extends to May 16, 2025. This contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zoryve 0.3% foam, a pharmaceutical product. The contract has a firm fixed price of $1,017.75 and a completion date of March 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567995030 - ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,158.98. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed-price delivery order contract awarded by the Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The total ceiling value of the contract is $3,699.34 and the ultimate completion date is May 16, 2025. The contract is not set-aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp is a for-profit...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $1,773.63 and a period of performance ending on September 9, 2024. This award is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and...
- This federal contract award is for a delivery order with a firm fixed price of $1,276.06, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of "ZORYVE 0.3% FOAM 60GM" and has an ultimate completion date of July 17, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical vendor for federal medical procurement needs, particularly for military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.52 firm fixed-price delivery order contract is for the provision of ZORYVE 0.3% FOAM 60GM medical supplies. The contract has a June 3, 2024 ultimate completion date and was awarded on May 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This is a $15,023.02 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 60 gram tubes of Zoryve 0.3% foam, a prescription topical medication, with a completion date of June 16, 2025. This award is associated with Amerisourcebergen's large $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZORYVE 0.3% FOAM 60GM, a pharmaceutical product, with a ceiling value of $1,106.13 and a completion date of May 13, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF48BDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,574.00, is for the provision of ZORYVE 0.3% FOAM 60GM, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 12, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/11/25 |